Efficacy/effectiveness Coverage Administration Modeling All age groups Mumps Measles Rubella
Vaccine/vaccination All age groups COVID-19 Measles Mumps Rubella
Efficacy/effectiveness All age groups Measles Mumps Rubella COVID-19
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Coverage Newborn (0-1 years) Children (2-9 years) Mumps Diphtheria Tetanus Pertussis Measles Rubella Poliomyelitis
Administration Efficacy/effectiveness Safety Newborn (0-1 years) Hepatitis B Diphtheria Pertussis Tetanus Haemophilus influenzae type B Poliomyelitis
Agenda & Minutes Argentina Measles
Agenda & Minutes Argentina Measles Poliomyelitis Meningococcal disease Yellow fever
Agenda & Minutes United States of America Human papillomavirus (HPV) Pneumococcal disease Measles Herpes zoster Pertussis Influenza Hepatitis A Meningococcal disease Dengue